Lumexa Imaging Holdings, Inc. (LMRI) has a MoatMap StockRank of 21/100 based on Quality (33/100), Value (38/100), and Momentum (36/100) factor scores. The current signal is SELL. Lumexa Imaging lacks the scale, validated regulatory moat, or pricing power required to fit our CDMO or healthcare-adjacent themes.
Information for the ticker LMRI and company name 'Lumexa Imaging Holdings, Inc.' as a publicly traded entity is not readily available on major exchanges or widely recognized financial data providers. It may refer to a private entity, a delisted stock, or a ticker associated with a different company or financial instrument not in public circulation.
| Price | $8.65 |
| Market Cap | $740M |
| P/E (Forward) | 9.21 |
| Price/Book | 1.32 |
| Return on Invested Capital | 5.4% |
| Debt/Equity | 161.34 |
| Gross Margin | 15.1% |
| Operating Margin | 3.5% |
| Revenue Growth | 3.1% |
Lumexa Imaging Holdings, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).